Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Primary Surgery Beneficial in Advanced Throat Cancers

By HospiMedica International staff writers
Posted on 04 Oct 2015
Patients with cancer of the mid- and lower throat may have higher survival rates if their initial treatment includes surgery, according to a new study.

Researchers at Koo Foundation Sun Yat-Sen Cancer Center (KFSYSCC; Taipei City, Taiwan) conducted an observational study, identifying all newly-diagnosed oropharyngeal (OP) and hypopharyngeal (HP) cancer patients in Taiwan, based on national health insurance claims and the Taiwan cancer registry database. More...
In all, 2,387 OP and 2,315 HP cancer patients diagnosed between 2004 and 2009 were identified, who were then followed until 2012. Radical surgery was performed on slightly more than one-third of OP cancer patients, while approximately half of HP cancer patients had surgery.

The researchers compared outcomes in those who had surgery and those who did not, regardless of whether they received concurrent chemoradiotherapy (CCRT). The results showed that for stage IVa OP cancer, overall survival at five years was 51% for those who had surgery versus 40% without. Similarly, in stage IVa HP cancer, 39% of those who had surgery were alive at five years, compared to 26%, of those who did not. The study was presented at the European Cancer Congress, held during September 2015 in Vienna (Austria).

“The emphasis on organ preservation has led to declining use of surgery. CCRT has become the standard approach for head and neck cancers which cannot be operated on, and it is being used alone even where surgery is possible,” said lead author and study presenter Chih-Tao Cheng, MD. “With the improvement of surgical techniques, including minimally invasive procedures, there's a need to revisit the various treatment options and look at the overall survival of different treatment groups.”

“Surgical treatment of advanced head and neck is a well-recognized weapon that is very often followed by radiotherapy with or without chemotherapy, followed by the assessment of risk from pathology samples,” commented Lisa Licitra, MD, of Istituto Nazionale Tumori (Milan, Italy), and spokesperson of the European Society for Medical Oncology (ESMO). “These data further underline the need to perform prospective research to elucidate the role of surgery and radiotherapy within the curative treatment approaches.”

The oropharynx connects the rear of the mouth to the top of the throat, and includes the posterior portion of the tongue and tonsils. The hypopharynx is the lower throat, which connects the oropharynx to the origin of the trachea and esophagus.

Related Links:

Koo Foundation Sun Yat-Sen Cancer Center
Istituto Nazionale Tumori



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
VTE Prevention System
Flowtron ACS900
Open Stapler
PROXIMATE Linear Cutter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.